Landmark Chinese trade secrets damages ruling carries important messages for rights holders
The Supreme People’s Court’s backing of a record payout to Sennics underscores an important shift away from the historic reluctance for large awards
The Supreme People’s Court’s backing of a record payout to Sennics underscores an important shift away from the historic reluctance for large awards
Anaqua AcclaimIP's analysis found that US companies, which earn the most US patents, increased their number of 2023 patents by 18% year-over-year
A leather and fabric care manufacturer’s lawsuit against an independent testing company will once again probe the power of NDAs in protecting trade secrets
Clarivate data covering 2018 to 2023 reveals a dynamic landscape, including booming industries and Lenovo’s entry into the top 100
17 November 2023
The Japanese photography giant’s actions stir old conflicts and boost the small number of East Asian companies using the new court
27 October 2023
Some patent litigators observe that patent disputes involving less complicated technologies tend to settle faster after claim construction. What does Docket Navigator data say?
27 September 2023
The Korean chemicals giant will do anything to combat “harsh competition” and IP is one of the “crucial” tools for securing success, contends IP head Kyung-Hwa Min
13 September 2023
Recent pair of lawsuits in lithium battery industry evince a pattern of companies using a ‘patent blocking’ strategy
18 August 2023
Docket Navigator shows Hall has presided over nearly 190 patent cases as a judge and previously had patent litigation experience in private practice
10 July 2023
PatSnap’s “State of IP” report reveals intelligence about patent value, monetisation strategies, IP department budgets and more
11 May 2023
Brian Tenner sits down with IAM to discuss the company’s win and future strategy
06 March 2023
GW’s recent ANDA lawsuit is a landmark moment, but will remain untypical of cannabis IP litigation
06 February 2023
The onus of identifying known substances in pharmaceutical patent applications is on the Indian Patent Office, according to a new ruling, which provides fresh clarity for prospective applicants.
01 February 2023
Unlock unlimited access to all IAM content